Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Osteoporosis Reports
Published in: Current Osteoporosis Reports 4/2011

01-12-2011 | Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)

Vitamin D in the Persian Gulf: Integrative Physiology and Socioeconomic Factors

Authors: Jessica Fields, Nishant J. Trivedi, Edward Horton, Jeffrey I. Mechanick

Published in: Current Osteoporosis Reports | Issue 4/2011

Login to get access

Abstract

Countries of the Persian Gulf region—Bahrain, Iran, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates—have become increasingly modernized, resulting in a transformation of lifestyle based on technology, sedentary activity, lack of sunlight, and unhealthy dietary patterns. These factors have led to a higher prevalence not only of vitamin D undernutrition, but also chronic obesity, insulin resistance, prediabetes, and type 2 diabetes. This review explores the integrative physiologic effects of vitamin D with socioeconomic factors and propose a hypothesis-driven model for their contributions to obesity and diabetes in the Persian Gulf. Further research into these interactions may ultimately lead to novel preventive strategies and therapies for metabolic disorders in this geographic region.
Literature
1.
Poskitt EME. Countries in transition: underweight to obesity non-stop? Ann Trop Paediatr Int Child Health. 2009;11:1–11.CrossRef
2.
Misra A, Singhal N, Khurana L. Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils. J Am Coll Nutr. 2010;29:289–301.
3.
American Association of Clinical Endocrinologists. The long awaited Institute of Medicine report on "Dietary Reference Intakes for Calcium and Vitamin D" was released November 30th and is available. Available at: https://​www.​aace.​com/​node/​205. Accessed March 2011.
4.
Al-Kandari YY. Prevalence of obesity in Kuwait and its relation to sociocultural variables. Obes Rev. 2006;7:147–54.PubMedCrossRef
5.
Mabry RM, Reeves MM, Eakin EG, Owen N. Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review. Diab Med. 2010;27:593–7.CrossRef
6.
Bener A, Zirie M, Musallam M, Khader Y, et al. Prevalence of metabolic Syndrome According to Adult Treatment Panel III and International Diabetes Federation Criteria: A Population-Based Study. Metab Syndr Relat D. 2009;7:221–9.CrossRef
7.
Weiss AJ, Zaidi M, Mechanick JI. Pharmacological and biological therapies for metabolic bone disease in critical illness: an integrative physiology approach. Curr Drug Ther. 2010;5:48–57.
8.
Weiss AJ, Lipshtat A, Mechanick JI. A systems approach to bone pathophysiology. Ann N Y Acad Sci 2010; 9–24.
9.
Weiss AJ, Iqbal J, Zaidi N, et al. The skeletal subsystem as an integrative physiology paradigm. Curr Osteoporos Rep. 2010;8:168–77.PubMedCrossRef
10.
11.
12.
13.
14.
• Garland CF, French CB, Baggerly LL, Heaney RP. Vitamin D supplement doses and serum 25-Hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res. 2011;31:607–12. This study highlights the recent controversy surrounding vitamin D supplementation guidelines. The study demonstrates the anticancer roles of vitamin D at doses higher than those recommended by the IOM, while raising the lower limit on vitamin D toxicity to 10,000 IU/day.PubMed
15.
Vitamin D insufficiency and deficiency in children and adolescents. In: UpToDate. Basow DS, editor. Waltham, MA: UpToDate; 2011.
16.
Lips P. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol. 2007;103:620–5.PubMedCrossRef
17.
Hagenau T, Vest R, Gissel TN, et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int. 2009;20:133–40.PubMedCrossRef
18.
Saadi HF, Kazzam E, Ghurbana BA, Nicholls MG. Hypothesis: correction of low vitamin D status among Arab women will prevent heart failure and improve cardia function in established heart failure. Eur J Hear Fail. 2006;8:694–6.CrossRef
19.
El-Kaissi S, Sherbeeni S: Vitamin D deficiency in the middle east and its health consequences for adults from nutrition and health. In: Holick MF, editor. Vitamin D. Springer Science; 2010:495–503.
20.
Mithal A, Wahl DA, Bonjour JP, Burckhardt P, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20:1807–20.PubMedCrossRef
21.
Ghannam NN, Hammami MM, Bakheet SM, Khan BA. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin d status, pregnancy, and lactation. Calcified Tissue Int. 1999;65:23–8.CrossRef
22.
Faraj S, Al Mutairi Khalaf. Vitamin D deficiency and chronic low back pain in Saudi Arabia. Spine. 2003;28:177–9.PubMedCrossRef
23.
Hosseinpanah F, Rombad M, Hossein-nejad A, et al. Association between vitamin D and bone mineral density in Iranian postmenopausal women. J Bone Min Metab. 2008;26:86–92.CrossRef
24.
Sadat-Ali M, AlElq A, Al-Turki Haifa, et al. Vitamin D levels in healthy men in eastern Saudi Arabia. Ann Saudi Med. 2009;29:378–81.PubMedCrossRef
25.
Glerup H, Mikkelsen K, Poulsen L, et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med. 2000;247:260–8.PubMedCrossRef
26.
Gallieni M. Vitamin D: physiology and pathophysiology. Int J Artif Organs. 2009;32:87–94.PubMed
27.
Arabi A, Rassi RE, Fuleihan GE. Hypovitaminosis D in developing countries – prevalence, risk factors and outcomes. Nat Rev Endocrinol. 2010;6:550–61.PubMedCrossRef
28.
Poskitt E. Introduction. In: Poskitt E, editor. Management of Childhood Obesity. Cambridge: Cambridge University Press; 2008. p. 1–14.CrossRef
29.
Al-Rethaiaa AS, Fahmy AA, Shwaiyat NM. Obesity and eating habits among college students in Saudi Arabia: a cross sectional study. Nutr J. 2010;9:1–10.CrossRef
30.
Jarallah Y. Domestic labor in the gulf countries. J Immig Refugee Stud. 2009;7:3–15.CrossRef
31.
Ramahi TM. Cardiovascular disease in the Asia Middle East region: global trends and local implications. Asia Pac J Public Health. 2010;22:83–9.CrossRef
32.
Musaiger AO. Socio-cultural and economic factors affecting food consumption patterns in the Arab countries. Perspectives in Public Health. 1993;113:68–74.
33.
Al-Sarraj T, Saadi H, Volek JS, Fernandez ML. Metabolic syndrome prevalence, dietary intake, and cardiovascular risk profile among overweight and obese adults 18–50 years old from the United Arab Emirates. Metab Syndr Relat Disord. 2010;8:39–46.PubMedCrossRef
34.
Al-Gazali LI, Alwash R, Abdulrazzaq YM. United Arab Emirates: communities and community genetics. Community Genet. 2005;8:186–96.PubMedCrossRef
35.
Al-Sultan FA, Al-Zanki N. Clinical epidemiology of type 2 diabetes Mellitus in Kuwait. Kuwait Med J. 2005;37:98–104.
36.
Yount KM, Sibai AM. Demography of aging in Arab countries. International Handbook of Population Aging. 2009;1:277–315.CrossRef
37.
Malik M, Razig SA. The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates: a report of a national survey. Metab Syndr Relat Disord. 2008;6:177–86.PubMedCrossRef
38.
Al-Lawati JA, Al-Hinai HQ, Mohammed AJ, Jousilahti P. Prevalence of the Metabolic Syndrome Among Omani Adults. Diabetes Care 2003; 1781–1785.
39.
Alsaif MA, Hakim IA, Harris RB, et al. Prevalence and risk factors of obesity and overweight in adult Saudi population. Nutr Res. 2001;22:1243–52.CrossRef
40.
Rasheed P. Perception of body weight and self-reporting eating and exercise behaviour among obese and non-obese women in Saudi Arabia. Public Health. 1998;112:409–14.PubMedCrossRef
41.
42.
• Ng SW, Zaghioui S, Ali HI, et al. The prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf States. Obes Rev. 2010;12:1–13. This study is both a unique and recent summary of the prevalence of various metabolic disorders in the Persian Gulf region..CrossRef
43.
Herr C, Greulich T, Koczulla RA, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res. 2011;12:1–9.CrossRef
44.
Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–3.PubMedCrossRef
45.
• Lou YR, Molnar F, Perakyla M, et al. 25-Hydroxyvitamin D3 is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol 2011; In Press. This study uses molecular modeling of the low- and high-affinity conformations of the VDRs to demonstrate the phylogenetically more ancient roles of 25(OH)D compared with its metabolite 1,25 2(OH)D. The study also uses murine and cell models to demonstrate the role 25(OH)D plays in metabolism as well as its antitumor properties.
46.
• Osei K. 25-OH Vitamin D: is it the universal panacea for metabolic syndrome and type 2 diabetes? J Clin Endocrinol Metab. 2010;95:4220–2. This study proposes mechanisms to tie vitamin D nutriture to extraskeletal health, such as maintaining glucose homeostasis and mitigating inflammatory processes.PubMedCrossRef
47.
48.
Arunabh S, Pollack S, James Y, Aloia JF. Body fat content and 25-Hydroxyvitamin D Levels in healthy women. Endocrine Care. 2003;88:157–61.CrossRef
49.
Garcia OP, Long KZ, Rosado JL. Impact of micronutrient deficiencies on obesity. Nutr Rev. 2009;67:559–72.PubMedCrossRef
50.
Menendez C, Lage M, Peino R, et al. Retinoic acid and vitamin D(3) powerfully inhibit in vitro leptin secretion by human adipose tissue. J Endocrinol. 2001;170:425–31.PubMedCrossRef
51.
Kong J, Li YC. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3 T3-L1 cells. Am J Physiol Endocrinol Metab. 2006;290:916–24.CrossRef
52.
Ochs-Balcom HM, Chennamaneni R, Millen AE, et al. Vitamin D receptor gene polymorphisms are associated with adiposity phenotypes. Am J Clin Nutr. 2011;93:5–10.PubMedCrossRef
53.
Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, et al. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr. 2007;26:573–80.PubMedCrossRef
54.
del Pino-Montes J, Benito GE, Fernandez-Salazar MP, et al. Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats. Calcified Tissue Int. 2003;75:526–32.CrossRef
55.
Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10:185–97.PubMedCrossRef
56.
Chiu KC, Chu A, Go VLW, et al. Hypovitaminosis D is associated with insulin resistance and β-cell dysfunction. Am J Clin Nutr. 2004;79:820–5.PubMed
57.
Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503–11.PubMedCrossRef
58.
Thadhani R, Manson JE. Vitamin D for cardiovascular disease prevention in women: state of the evidence. Curr Cardio Risk Rep. 2010;4:216–21.CrossRef
59.
Zittermann A, Gummert JF. Sun, vitamin D, and cardiovascular disease. J Photochem Photobiol B: Biol. 2010;101:124–9.CrossRef
60.
Al-Ghawi A, Uauy R. Study of the knowledge, attitudes and practices of physicians towards obesity management in primary health care in Bahrain. Public Health Nutr. 2009;10:1791–8.CrossRef
61.
Al-Rashdan I, Al-Nesef Y. Prevalence of overweight, obesity, and metabolic syndrome among adult Kuwaitis: results from community-based national survey. Angiology. 2010;61:42–8.PubMedCrossRef
62.
Musallam M, Bener A, Zirie M, et al. Metabolic Syndrome and its components among Qatari population. Int J Food Saf Nutr Publ Health. 2008;1:88–102.CrossRef
63.
Al-Nozha MM. Metabolic syndrome in Saudi Arabia. Saudi Med J. 2005;26:1918–25.PubMed
64.
Baynouna LM, Revel AD, Nagelkerke NJ, et al. High prevalence of the cardiovascular risk factors in Al-Ain, United Arab Emirates. Saudi Med J. 2008;29:1173–8.PubMed
65.
Metadata
Title
Vitamin D in the Persian Gulf: Integrative Physiology and Socioeconomic Factors
Authors
Jessica Fields
Nishant J. Trivedi
Edward Horton
Jeffrey I. Mechanick
Publication date
01-12-2011
Publisher
Current Science Inc.
Published in
Current Osteoporosis Reports / Issue 4/2011
Print ISSN: 1544-1873
Electronic ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-011-0071-2

Other articles of this Issue 4/2011

Current Osteoporosis Reports 4/2011 Go to the issue

Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)

Microarchitectural Changes in the Aging Skeleton

Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)

Platelet-Rich Plasma for the Replenishment of Bone

Pediatrics and Skeletal Development (Craig Langman and Maria Luisa Bianchi, Section Editors)

Rickets

Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)

Rodent Models of Aging Bone: An Update

Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)

Stem Cell Interactions in a Bone Marrow Niche

Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)

Bone, Inflammation, and Inflammatory Bowel Disease